SCHEMBL28629464

SCHEMBL28629464

CS(=O)(=O)OCC1C[C](OCc2ccccc2)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 6/20 0.41
NPC1 O15118 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA9 Q16790 2/20 0.40
CA12 O43570 1/20 0.38
CA4 P22748 1/20 0.38
CA5A P35218 1/20 0.38
CA7 P43166 1/20 0.38
CA5B Q9Y2D0 1/20 0.38
BUB1 O43683 1/20 0.38
CYP19A1 P11511 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16398438 0.78 CTSL (0.45) CA1CA2CA9
SCHEMBL16398437 0.78 CTSL (0.45) CA1CA2CA9
SCHEMBL10171982 0.78 CTSL (0.42) CA1CA2CA9BUB1
SCHEMBL583025 0.77 FFAR1 (0.43) ARNPC1HPGDRAB9ASMN1; SMN2
SCHEMBL7214509 0.76 IDO1 (0.41) CA1CA2BUB1CYP19A1ALDH1A1
SCHEMBL30324809 0.75 OPRM1 (0.45) CA1CA2CA9
SCHEMBL249386 0.73 CA2 (0.63) ARNPC1HPGDRAB9ASMN1; SMN2
Benzene SCHEMBL27447210 0.73 CA2 (0.63) ARNPC1HPGDRAB9ASMN1; SMN2
SCHEMBL28283611 0.73 SLC6A2 (0.44) NPC1RAB9ASMN1; SMN2MAPTMAPK1
SCHEMBL20282868 0.72 LTA4H (0.47) MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114057739-A Diazepinone derivatives and their use in the treatment of hepatitis b infections 诺维拉治疗公司 2022-02-18 CN disclosed
CN-109641896-B Diazepinone derivatives and their use in the treatment of hepatitis b infections 诺维拉治疗公司 2021-09-21 CN disclosed